<--GAT-->

Recent Oncology Studies November 2010

by U.S. Medicine

November 14, 2010

Studying Genes, Environment, and Prostate Cancer Risk

Objective: The study has four objectives: to evaluate the evidence of familial aggregation for prostate cancer and identify a homogenous subgroup of families with elevated likelihood of aggressive disease using a family case-control design; to determine if genetic variation in selected genes involved in reactive oxygen species detoxification and the oxidative stress response are independently or jointly associated with greater mitochondrial DNA damage and increased prostate cancer risk; to determine if dietary intake of ω-3 fatty acids alters the risk of prostate cancer; and to determine the association between variation in genes involved in ROS detoxification, oxidative stress response, and prostate cancer risk.

Sponsor: VA

Contact: Jackilen Shannon, PhD, Portland VAMC, [email protected]

Status: Recruiting

Skin Cancer Prevention

Objective: To see if 5-fluorouracil (5-FU) skin cream can prevent the growth of new skin cancers on the face and ears. The cost of trying to prevent skin cancer will be compared to the usual cost of treating skin cancer. Patients recruited in the study will have been treated for two or more skin cancers within the past five years, with at least one having been on their face or ears.

Sponsor: VA

Contact: Patricia Baldwin, RN, [email protected]

Status: Recruiting

Combination Targeted Radiotherapy in Neuroendocrine Tumors

Objective: To determine what fraction of individuals with neuroendocrine tumors would show improved tumor dosimetry with combined agent therapy compared to “best” single agent therapy and determine the magnitude of the potential tumor radiation dose increase. Researchers plan to perform serial scintigraphic imaging procedures to measure patient specific bone marrow, kidney, and tumor biodistribution and kinetics for 111In pentetreotide and 131I-MIBG in adults and children with neuroendocrine tumors. Using the program already developed, they will input the individual dosimetry measures for bone marrow, kidney, and tumor to determine the optimal amounts of administered radioactivity for the combination of 131I MIBG plus 90Y DOTATOC or 131I MIBG alone.

Sponsor: VA

Contact: Dr David Bushnell, Iowa City VAMC

Status: Recruiting by invitation only

Cap Assisted Colonoscopy for the Detection of Colon Polyps

Objective: The investigators hypothesize that adenoma detection rate will be higher using cap assisted colonoscopy compared to standard colonoscopy. Also, cap assisted colonoscopy will be safe
and cecal intubation rate will be similar compared to standard colonoscopy. The study will: compare the prevalence of adenomas detected by standard colonoscopy and cap assisted colonoscopy; compare the number of adenomas detected per subject by standard colonoscopy and cap assisted colonoscopy; and compare the cecal intubation rate, insertion time, withdrawal time, and complications of standard colonoscopy and cap assisted colonoscopy.

Sponsor: American Society for Gastrointestinal Endoscopy (with data provided by Kansas City VAMC)

Contact: Deepthi Rao, [email protected]

Status: Recruiting

back to November articles


Related Articles

VA/National Cancer Institute Partnership Increases Veteran Access to Trials

Thanks to a new partnership between the National Cancer Institute and the VA, veterans with cancer will now have greater access to potentially lifesaving clinical trials.

VA Continues Hepatocellular Screening, but Study Questions the Value

Although a recent study determined that screening veterans with cirrhosis for hepatocellular carcinoma did not reduce the risk of death associated with liver cancer, the VA has no plans to change its screening practices.


U.S. Medicine Recommends


More From research

Research

First-Ever Study Focuses on How Well VHA Cares for TIA Patients

INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help avoid acute events altogether.

Research

Link Between Pain, Brain Disruption in Gulf War Veterans

A study at the Road Home Program at Rush University Medical Center, shown here, suggests that short-term intensive outpatient treatment might be more effective for post-traumatic stress disorder (PTSD) in military veterans than longer-term therapy.... View Article

Research

VA Patients Lack Testing to Optimize CLL Treatment

SALT LAKE CITY — The presence of deletion 17p (del17), determined by chromosome analysis and/or fluorescence in situ hybridization (FISH), is a strong negative prognostic marker in chronic lymphocytic leukemia (CLL), according to a report in the Journal of Clinical Oncology.1

Research

Early Relapse After AHCT Bad Sign in Multiple Myeloma

A study at the Road Home Program at Rush University Medical Center, shown here, suggests that short-term intensive outpatient treatment might be more effective for post-traumatic stress disorder (PTSD) in military veterans than longer-term therapy.... View Article

Research

Laparoscopic, Robotic Surgeries Equivalent for Pancreatic Cancer

Pancreatic cancer patients increasingly are receiving minimally invasive pancreaticoduodenectomy (MIPD).

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up